Tag: mepolizumab

Biologics in Severe Asthma: How Anti-IgE and Anti-IL-5 Therapies Change the Game

Biologics in Severe Asthma: How Anti-IgE and Anti-IL-5 Therapies Change the Game

| 11:15 AM | 0

Anti-IgE and anti-IL-5 biologics are transforming severe asthma care by targeting specific immune pathways. Learn how omalizumab, mepolizumab, and benralizumab reduce flare-ups, cut steroid use, and restore quality of life for those who don’t respond to standard treatments.

read more